• 60.6k views

Critical Care Procedures Done in COVID ICU

Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.

About the Speaker

Dr. Aklesh Tandekar Profile Image

Dr. Aklesh Tandekar

CRITICAL CARE SPECIALIST MD, EDIC, IDCCM, FIMSA, DA, FCPS, FISCCM

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Aklesh Tandekar's Talks on Assimilate

webinar
Dr. Aklesh Tandekar
  • 0

Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.

webinar
Dr. Aklesh Tandekar
  • 0

Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.

webinar
Dr. Aklesh Tandekar
  • 0

Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.